A Phase II, Open-Label, Multi-Drug, Multi-Centre, Master Protocol to Evaluate the Efficacy and Safety of Novel Bispecific Antibodies as Monotherapy and in Combination with Anticancer Agents in Participants with Advanced Hepatobiliary Cancer D7987C00001 GEMINI

Brief Summary

Type:
Liver

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT05775159

Study #:
STUDY00150636

Start Date:
Jan 18, 2024

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT05775159

View Complete Trial Details & Eligibility at ClinicalTrials.gov